La Roche-Posay
La Roche-Posay Effaclar A.I. Breakout Corrector
Targeted breakout corrector for individual blemishes
3
Bien
19
Neutre
0
Mise en garde
0
Éviter
14% bien
86% neutre
0% mise en garde
0% éviter
Survolez une ligne · cliquez pour la carte
Water
Aqua
solvent
→
Cyclohexasiloxane
emollient hair conditioning skin conditioning solvent
→
Isononyl Isononanoate
antistatic emollient skin conditioning
→
Propylene Glycol
humectant skin conditioning solvent viscosity controlling
→
Isohexadecane
emollient skin conditioning solvent
→
Niacinamide
vitamin B3, nicotinamide
smoothing
→
PEG-100 Stearate
surfactant
→
Glyceryl Stearate
emollient emulsifying
→
Cetyl Alcohol
emollient emulsifying emulsion stabilising foam boosting masking opacifying surfactant viscosity controlling
→
Magnesium Aluminum Silicate
absorbent anticaking opacifying viscosity controlling
→
Carbomer
emulsion stabilising gel forming viscosity controlling
→
Sodium Hydroxide
lye
buffering denaturant
→
Capryloyl Glycine
cleansing hair conditioning surfactant
→
Capryloyl Salicylic Acid
LHA
skin conditioning
→
Citric Acid
buffering chelating masking
→
Xanthan Gum
binding emulsifying emulsion stabilising gel forming skin conditioning surfactant viscosity controlling
→
Acrylates Copolymer
antistatic binding film forming
→
Salicylic Acid
BHA
antidandruff hair conditioning keratolytic masking preservative skin conditioning
→
Iodopropynyl Butylcarbamate
preservative
→
Chlorhexidine Digluconate
antimicrobial oral care preservative
→
Piroctone Olamine
preservative
→
Parfum/Fragrance
Fragrance, Parfum
Состав
Water, Cyclohexasiloxane, Isononyl Isononanoate, Propylene Glycol, Isohexadecane, Niacinamide, PEG-100 Stearate, Glyceryl Stearate, Cetyl Alcohol, Magnesium Aluminum Silicate, Carbomer, Sodium Hydroxide, Capryloyl Glycine, Capryloyl Salicylic Acid, Citric Acid, Xanthan Gum, Acrylates Copolymer, Salicylic Acid, Iodopropynyl Butylcarbamate, Chlorhexidine Digluconate, Piroctone Olamine, Parfum/Fragrance
Trouver des produits similaires…
L'historique des modifications n'est pas encore suivi